The British are not stupid old chaps and they are hardly going to rely only on one antiviral, Tamiflu. You would have to give Relenza a good chance. Indeed!
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
